Williams Babalola
International news platform, CNN, in a recent report has revealed the reason why some people test positive to coronavirus even after COVID-19 vaccination.
According to health experts, although Pfizer and Moderna vaccines have been approved to combat COVID-19, they both do not provide complete and instant protection against the virus.
The US Centers for Disease Control and Prevention reported that the vaccine takes a few weeks for it to start building a strong immune system and as such, the virus could have been in the victim’s system before getting vaccinated.
The news platform cited an example of Democratic Representative, Stephen Lynch, of Massachusetts who tested positive even after he got his second dose of the Pfizer vaccine.
In a new perspective piece published in the Feb. 5 issue of
Science, pharmacologist Namandje Bumpus, Ph.D. who recently became the first African American woman to head a Johns Hopkins University School of Medicine department, and is the only African American woman leading a pharmacology department in the country outlines the molecular origins for differences in how well certain drugs work among distinct populations. She also lays out a four-part plan to improve the equity of drug development. Human beings are more similar than we are different, says Bumpus. Yet, the slightest variations in our genetic material can cause big differences in how well drugs work in our bodies. This is not a new idea.